Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Aug 18, 2021
Open Peer Review Period: Aug 11, 2021 - Aug 25, 2021
Date Accepted: Oct 5, 2021
Date Submitted to PubMed: Nov 4, 2021
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study

Lami F, Elfadul M, Rashak HA, Al Nsour M, Akhtar H, Khader YS, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha HA, Zayer RH, Aljanabe AH, Ali NA, Ikram A, Rahman Fu, Khan MM, Adam R, Ahmed AY, Afifi S

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study

JMIR Public Health Surveill 2022;8(3):e32831

DOI: 10.2196/32831

PMID: 34736222

PMCID: 8929409

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: A Multicountry Retrospective Study .

  • Faris Lami; 
  • Maisa Elfadul; 
  • Hiba Abdulrahman Rashak; 
  • Mohannad Al Nsour; 
  • Hashaam Akhtar; 
  • Yousef S. Khader; 
  • Ahmed Mohamud Hussein; 
  • Mariam Naciri; 
  • Sahar Samy; 
  • Yasser Ghaleb; 
  • Hana Ahmad Taha; 
  • Raheem Hussein Zayer; 
  • Alaa Hussein Aljanabe; 
  • Nameer Abdulkareem Ali; 
  • Aamer Ikram; 
  • Fazal ur Rahman; 
  • Muhammad Mujeeb Khan; 
  • Reema Adam; 
  • Abdirizak Yusuf Ahmed; 
  • Salma Afifi

ABSTRACT

Background:

The establishment of empirical evidence in the Eastern Mediterranean Region (EMR) necessitates the implementation of wide-scale studies to describe the demographic, clinical features, and severity profile ofCOVID-19 patients.

Objective:

Hence, this study aimed to to assess the patterns of COVID-19 severity and mortality in seven countries and to determine the risk factors of COVID-19 severity and mortality.

Methods:

This multi-country study was based on a retrospective review of medical records of hospitalized patients confirmed to have COVID-19. This study included data from Iraq, Pakistan, Sudan, Somalia, Morocco, Egypt, and Yemen. All demographic and clinical data were extracted from hospital records (paper files) by trained data collectors.

Results:

A total of 4141 patients were included in this study from seven countries. Comorbidities were reported by nearly half of the patients, with hypertension (HT)(24.7%)and diabetes (22.7%) being the most common. Older age, diabetes mellitus, hypertension, and heart diseases were significantly associated with COVID-19 severity and mortality. Ever smoking and renal diseases were significantly associated with severity but not mortality, while male gender, respiratory diseases, and malignancy were significantly associated with mortality but not severity.

Conclusions:

The study confirmed the role of comorbidities and demographic features on the severity and mortality of COVID-19. Understanding the contributing factors ensures attentive care and informs clinical management of patients with poorer prognosis in early stages of


 Citation

Please cite as:

Lami F, Elfadul M, Rashak HA, Al Nsour M, Akhtar H, Khader YS, Hussein AM, Naciri M, Samy S, Ghaleb Y, Taha HA, Zayer RH, Aljanabe AH, Ali NA, Ikram A, Rahman Fu, Khan MM, Adam R, Ahmed AY, Afifi S

Risk Factors of COVID-19 Critical Outcomes in the Eastern Mediterranean Region: Multicountry Retrospective Study

JMIR Public Health Surveill 2022;8(3):e32831

DOI: 10.2196/32831

PMID: 34736222

PMCID: 8929409

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.